CRDF earnings: a positive outcome, +10.0%

On August 4, 2022, Cardiff Oncology, Inc. reached its earnings. The result was a positive outcome, and the stock moved +10.0% in the window around the event. It had already run -26.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.